Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

CAPN3 – Limb-girdle muscular dystrophy, autosomal dominant 4

Autosomal dominant transmission of CAPN3-related limb-girdle muscular dystrophy (LGMDD4) has been described in two independent kindreds carrying the recurrent c.759_761del (p.Lys254del) variant in CAPN3. Both families presented with camptocormia, progressive proximal weakness, myalgia, back pain and elevated creatine kinase levels, but heterozygous carriers of the same variant in recessive LGMDR1 pedigrees were asymptomatic, indicating incomplete penetrance or the requirement for additional modifier factors ([PMID:38299438]). This limited genetic evidence, with only two probands and absence of segregation in obligate carriers, yields a Limited clinical validity classification. No functional studies have specifically evaluated the p.Lys254del variant in a dominant context, and pathogenicity remains unconfirmed.

References

  • Neurology • 2023 • Dominant versus recessive phenotypic effects of the CAPN3 p.Lys254del variant in limb-girdle muscular dystrophy PMID:38299438

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

2 probands, no segregation in heterozygous carriers, incomplete penetrance undermining causality ([PMID:38299438])

Genetic Evidence

Limited

Single recurrent variant c.759_761del (p.Lys254del) identified in two LGMDD4 families but heterozygous carriers in recessive families are asymptomatic ([PMID:38299438])

Functional Evidence

Limited

No functional studies specific to the p.Lys254del variant in a dominant context